

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in surgical management of urinary... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/8-1294/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/8-1294" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in surgical management of urinary incontinence" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in surgical management of urinary incontinence.">
            <meta name="og:description" content="Read the latest article version by Alison Downey, Richard D. Inman, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="17866">
            <meta name="article-id" content="16356">
            <meta name="dc.title" content="Recent advances in surgical management of urinary incontinence">
            <meta name="dc.description" content="There have been several recent developments in surgical treatments for male and female incontinence. This article reviews the current options for treatments of urge and stress incontinence in men and women. Treatments for urge incontinence discussed include intradetrusor onabotulinum toxin A, sacral neuromodulation and percutaneous tibial nerve stimulation. For stress incontinence, suburethral mesh, bulking agents, autologous slings, colposuspension, male slings and artificial urinary sphincters are assessed.">
            <meta name="dc.subject" content="Surgery, Urinary Incontinence, Bladder, stress incontinence, urgency incontinence">
            <meta name="dc.creator" content="Downey, Alison">
            <meta name="dc.creator" content="Inman, Richard D.">
            <meta name="dc.date" content="2019/07/31">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.16356.1">
            <meta name="dc.source" content="F1000Research 2019 8:1294">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Surgery">
            <meta name="prism.keyword" content="Urinary Incontinence">
            <meta name="prism.keyword" content="Bladder">
            <meta name="prism.keyword" content="stress incontinence">
            <meta name="prism.keyword" content="urgency incontinence">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2019/07/31">
            <meta name="prism.volume" content="8">
            <meta name="prism.number" content="1294">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.16356.1">
            <meta name="prism.url" content="https://f1000research.com/articles/8-1294">
            <meta name="citation_title" content="Recent advances in surgical management of urinary incontinence">
            <meta name="citation_abstract" content="There have been several recent developments in surgical treatments for male and female incontinence. This article reviews the current options for treatments of urge and stress incontinence in men and women. Treatments for urge incontinence discussed include intradetrusor onabotulinum toxin A, sacral neuromodulation and percutaneous tibial nerve stimulation. For stress incontinence, suburethral mesh, bulking agents, autologous slings, colposuspension, male slings and artificial urinary sphincters are assessed.">
            <meta name="citation_description" content="There have been several recent developments in surgical treatments for male and female incontinence. This article reviews the current options for treatments of urge and stress incontinence in men and women. Treatments for urge incontinence discussed include intradetrusor onabotulinum toxin A, sacral neuromodulation and percutaneous tibial nerve stimulation. For stress incontinence, suburethral mesh, bulking agents, autologous slings, colposuspension, male slings and artificial urinary sphincters are assessed.">
            <meta name="citation_keywords" content="Surgery, Urinary Incontinence, Bladder, stress incontinence, urgency incontinence">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Alison Downey">
            <meta name="citation_author_institution" content="Department of Urology, Royal Hallamshire Hospital, Glossop Road, Sheffield, S10 2JF, UK">
            <meta name="citation_author" content="Richard D. Inman">
            <meta name="citation_author_institution" content="Department of Urology, Royal Hallamshire Hospital, Glossop Road, Sheffield, S10 2JF, UK">
            <meta name="citation_publication_date" content="2019/07/31">
            <meta name="citation_volume" content="8">
            <meta name="citation_publication_number" content="1294">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.16356.1">
            <meta name="citation_firstpage" content="1294">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/8-1294/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/8-1294.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=17866 /> <input type=hidden id=articleId name=articleId value=16356 /> <input type=hidden id=xmlUrl value="/articles/8-1294/v1/xml"/> <input type=hidden id=xmlFileName value="-8-1294-v1.xml"> <input type=hidden id=article_uuid value=fad0225b-4af5-4659-b977-d8e8f4cc5dfa /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in surgical management of urinary incontinence"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.16356.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.16356.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/8-1294"
  },
  "headline": "Recent advances in surgical management of urinary incontinence",
  "datePublished": "2019-07-31T14:31:47",
  "dateModified": "2019-07-31T14:31:47",
  "author": [
    {
      "@type": "Person",
      "name": "Alison Downey"
    },    {
      "@type": "Person",
      "name": "Richard D. Inman"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "There have been several recent developments in surgical treatments for male and female incontinence. This article reviews the current options for treatments of urge and stress incontinence in men and women. Treatments for urge incontinence discussed include intradetrusor onabotulinum toxin A, sacral neuromodulation and percutaneous tibial nerve stimulation. For stress incontinence, suburethral mesh, bulking agents, autologous slings, colposuspension, male slings and artificial urinary sphincters are assessed."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/8-1294/v1",
            "name": "Recent advances in surgical management of urinary incontinence"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in surgical management of urinary incontinence </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=17866 data-id=16356 data-downloads="" data-views="" data-scholar="10.12688/f1000research.16356.1" data-recommended="" data-doi="10.12688/f1000research.16356.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/8-1294/v1/pdf?article_uuid=fad0225b-4af5-4659-b977-d8e8f4cc5dfa" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-16356-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-16356-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-16356-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Downey A and Inman RD. Recent advances in surgical management of urinary incontinence [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):1294 (<a class=new-orange href="https://doi.org/10.12688/f1000research.16356.1" target=_blank>https://doi.org/10.12688/f1000research.16356.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-16356-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=16356 id=track-article-signin-16356 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/16356?target=/articles/8-1294/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=17866 /> <input name=articleId type=hidden value=16356 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in surgical management of urinary incontinence</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Alison Downey,&nbsp;</span><span class=""><a href="mailto:richard.inman@sth.nhs.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Richard D. Inman</span></a><a href="https://orcid.org/0000-0001-6721-5418" target=_blank id=author-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-6721-5418</div></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Alison Downey,&nbsp;</span><span class=""><a href="mailto:richard.inman@sth.nhs.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Richard D. Inman</span></a><a href="http://orcid.org/0000-0001-6721-5418" target=_blank id=mauthor-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-6721-5418</div></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 31 Jul 2019 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.16356.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Department of Urology, Royal Hallamshire Hospital, Glossop Road, Sheffield, S10 2JF, UK<br/> <p> <div class=margin-bottom> Alison Downey <br/> <span>Roles: </span> Writing  Original Draft Preparation, Writing  Review & Editing </div> <div class=margin-bottom> Richard D. Inman <br/> <span>Roles: </span> Formal Analysis, Methodology, Project Administration, Supervision, Validation, Writing  Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=14436-51416></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=54354-51419></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> There have been several recent developments in surgical treatments for male and female incontinence. This article reviews the current options for treatments of urge and stress incontinence in men and women. Treatments for urge incontinence discussed include intradetrusor onabotulinum toxin A, sacral neuromodulation and percutaneous tibial nerve stimulation. For stress incontinence, suburethral mesh, bulking agents, autologous slings, colposuspension, male slings and artificial urinary sphincters are assessed. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Surgery, Urinary Incontinence, Bladder, stress incontinence, urgency incontinence </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Richard D. Inman (<a href="mailto:richard.inman@sth.nhs.uk">richard.inman@sth.nhs.uk</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Richard D. Inman </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp;  2019 Downey A and Inman RD. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Downey A and Inman RD. Recent advances in surgical management of urinary incontinence [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):1294 (<a href="https://doi.org/10.12688/f1000research.16356.1" target=_blank>https://doi.org/10.12688/f1000research.16356.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 31 Jul 2019, <b>8</b>(F1000 Faculty Rev):1294 (<a href="https://doi.org/10.12688/f1000research.16356.1" target=_blank>https://doi.org/10.12688/f1000research.16356.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 31 Jul 2019, <b>8</b>(F1000 Faculty Rev):1294 (<a href="https://doi.org/10.12688/f1000research.16356.1" target=_blank>https://doi.org/10.12688/f1000research.16356.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d41170e149>Introduction</h2><p class="" id=d41170e152>Urinary incontinence is defined by the International Continence Society as any involuntary leak of urine<sup><a href="#ref-1">1</a></sup>. Classification of urinary incontinence includes stress incontinence, urgency incontinence, mixed incontinence and continuous incontinence (for example, due to vesicovaginal fistula). This review concentrates on the surgical management of urgency and stress incontinence.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d41170e162>Urge urinary incontinence</h2><p class="" id=d41170e165>Urge urinary incontinence (UUI) is defined as involuntary leakage of urine accompanied or immediately preceded by urgency and is part of the symptom complex of overactive bladder syndrome (OAB)<sup><a href="#ref-1">1</a></sup>. A systematic review of global prevalence and economic burden of UUI estimated a prevalence of between 1.85 and 30.5% in Europe and an annual cost of $7 billion in Canada, German, Italy, Spain, Sweden and the UK<sup><a href="#ref-2">2</a></sup>.</p><p class="" id=d41170e176>Non-surgical management of OAB consists of a stepwise approach. First-line options include lifestyle modifications such as bladder drill (or timed voiding, a self-help regimen designed to increase the interval between voids by using a graduated approach), reducing intake of caffeinated drinks, and preventative measures such as treatment of constipation and weight loss<sup><a href="#ref-3">3</a><a href="#ref-5">5</a></sup>.</p><p class="" id=d41170e186>If conservative methods are not sufficient, second-line therapies involve adding anticholinergic medications and, more recently, mirabegron, a beta-adrenergic receptor agonist approved in 2012 and recommended as a second-line treatment for UUI by the European Association of Urology (EAU), the American Association of Urology (AUA) and the National Institute for Health and Clinical Excellence (NICE)<sup><a href="#ref-6">6</a>,<a href="#ref-7">7</a></sup>.</p><p class="" id=d41170e196>When patients are resistant to or cannot tolerate both conservative and pharmacological treatment, surgical techniques such as intravesical onabotulinum toxin A (oBTXA), sacral neuromodulation, and posterior tibial nerve stimulation are third-line options. In those refractory to all treatments, augmentation cystoplasty or urinary diversion can be considered as a final option.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d41170e202>Onabotulinum toxin A</h2><p class="" id=d41170e205>Injection of oBTXA, a potent neurotoxin, into the bladder wall is now recommended for use in patients who have OAB with or without UUI and who have failed to respond to conservative and drug treatments. It is injected by using a flexible or rigid cystoscope into the detrusor muscle under local or general anaesthetic. The main side effects of treatment are urinary tract infection (UTI), incomplete bladder emptying and urinary retention requiring clean intermittent self-catheterisation<sup><a href="#ref-8">8</a></sup>.</p><p class="" id=d41170e212>Substantial high-quality data comparing oBTXA with placebo and anticholinergic medication support the use of oBTXA as a third-line treatment for patients with UUI. In 2017, in a double-blinded placebo-controlled randomised controlled trial (RCT) of nearly 500 patients, Nitti <i>et al</i>. compared 100 units of oBTXA with placebo and found that oBTXA significantly decreased the frequency of UUI episodes compared with placebo (by 2.65 versus 0.87)<sup><a href="#ref-9">9</a></sup>. Complete continence also improved in 22.9% of patients having oBTXA compared with 6.5% with placebo at 24 weeks. Side effects of oBTXA included urinary retention and UTI (<a href="#T1">Table 1</a>)<sup><a href="#ref-9">9</a></sup>.</p><a name=T1 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 1. Comparison of onabotulinum toxin A versus placebo in treating urge urinary incontinence.</h3></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d41170e240 class=n-a></a><thead><a name=d41170e242 class=n-a></a><tr><a name=d41170e244 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d41170e246 class=n-a></a>At 12 weeks</th><th align=left colspan=1 rowspan=1 valign=top><a name=d41170e249 class=n-a></a>Placebo</th><th align=left colspan=1 rowspan=1 valign=top><a name=d41170e252 class=n-a></a>100 units of<br class=br>onabotulinum toxin A</th><th align=left colspan=1 rowspan=1 valign=top><a name=d41170e257 class=n-a></a><i>P</i> value</th></tr></thead><tbody><a name=d41170e264 class=n-a></a><tr><a name=d41170e266 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e268 class=n-a></a>Reduction in frequency</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e271 class=n-a></a>0.87 (12%)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e274 class=n-a></a>2.65 (49%)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e277 class=n-a></a>&lt;0.01</td></tr><tr><a name=d41170e281 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e283 class=n-a></a>Continent</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e286 class=n-a></a>6.5%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e289 class=n-a></a>22.9%</td><td align=left colspan=1 rowspan=1><a name=d41170e292 class=n-a></a></td></tr><tr><a name=d41170e295 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e297 class=n-a></a>Urinary tract infection</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e300 class=n-a></a>9.2%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e303 class=n-a></a>24.5%</td><td align=left colspan=1 rowspan=1><a name=d41170e306 class=n-a></a></td></tr><tr><a name=d41170e309 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e311 class=n-a></a>PVR of 200 mL or increase of 200 mL from baseline PVR</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e314 class=n-a></a>0%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e317 class=n-a></a>8.7%</td><td align=left colspan=1 rowspan=1><a name=d41170e320 class=n-a></a></td></tr><tr><a name=d41170e323 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e325 class=n-a></a>PVR of 200 mL or greater requiring CISC</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e328 class=n-a></a>0.4%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e331 class=n-a></a>5.8%</td><td align=left colspan=1 rowspan=1><a name=d41170e334 class=n-a></a></td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=FN1 class=n-a></a><p id=d41170e343> Data are from Nitti <i>et al</i>.<sup><a href="#ref-9">9</a></sup> (2017). CISC, clean intermittent self-catheterisation; PVR, post-void residual urine volume.</p></div></div></div><p class="" id=d41170e356>A 2017 systemic review comparing oBTXA with anticholinergics and mirabegron found that 100 units of oBTXA resulted in the greatest reduction in episodes of UUI and of continence (100% reduction in UUI) at 12 weeks, compared with all other licenced medication, although there was no difference in urinary frequency between oBTXA and either solifenacin 10 mg once a day or oxybutynin 10 mg controlled release once a day<sup><a href="#ref-10">10</a></sup>. However, there is currently a lack of direct head-to-head trials of oBTXA compared with anticholinergics and mirabegron.</p><p class="" id=d41170e364>As a result of the high-quality data available, most guidelines recommend oBTXA for refractory OAB symptoms. NICE now recommends offering oBTXA to patients with proven detrusor overactivity at an initial dose of 200 units; however, EAU guidelines recommend an initial dose of 100 units<sup><a href="#ref-6">6</a>,<a href="#ref-7">7</a></sup>. Patients should be counselled about the 5% risk of urinary retention requiring clean intermittent self-catheterisation, the requirement for repeat injections every 6 to 9 months and the increased risk of associated UTI.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d41170e377>Sacral neuromodulation</h2><p class="" id=d41170e380>Sacral neuromodulation (SNM) involves the placement of an electrode into the third sacral (S3) foramen which is connected to a generator and battery, electrically stimulating the nerve root and suppressing the reflexes responsible for involuntary detrusor contractions. Currently, sacral nerve stimulation (SNS) is recommended in those who have failed or cannot tolerate conservative and pharmacological treatment, as an alternative to oBTXA (EAU<sup><a href="#ref-6">6</a></sup>) or those unsuitable for oBTXA.</p><p class="" id=d41170e387>Historically, implantation of a permanent SNS generator was preceded by a trial of percutaneous electrode linked to an external stimulator for a trial of stimulation, and success was defined as more than 50% clinical improvement after 1 to 2 weeks. At a later date, a permanent tined lead and battery were implanted.</p><p class="" id=d41170e390>Recently, in 2015, a permanent tined electrode was inserted initially for the trial period and a permanent generator was implanted 2 weeks later without removal of the tined lead if the trial was successful<sup><a href="#ref-11">11</a></sup>. Comparison of the two implantation techniques has shown that the two-stage technique results in a higher rate of generator implantation and this is probably due to the improved stability of a permanent tined lead (50.9% versus 24.1%)<sup><a href="#ref-11">11</a></sup>.</p><p class="" id=d41170e401>In a 2018 systematic review of neuromodulation, Tutolo <i>et al</i>. showed that, in those with UUI, between 43 and 56% of patients were dry and 54 to 59% were improved and that the long-term results are maintained at 4 years<sup><a href="#ref-12">12</a></sup>. SNS is a safe procedure; the commonest side effects are pain at the implantation site in 15 to 42%, revision surgery in 9 to 33% and wound infections in 3 to 6%. Despite the promising results, studies of SNS have often not blinded assessors to treatments and patient allocation has been open to bias.</p><p class="" id=d41170e412>However, the recently reported ROSETTA (Refractory Overactive Bladder: Sacral NEuromodulation vs. BoTulinum Toxin Assessment) trial was a good-quality multi-centre open-label randomised study comparing oBTXA (200 units) with SNS in 386 women<sup><a href="#ref-13">13</a></sup>. oBTXA treatment had a small but statistically significantly increased reduction in mean number of UUI episodes (3.9 versus 3.3) at 6 months. The oBTXA group had a higher rate of UTI (35% versus 11%) and requirement for self-catherisation (8% at 1 month and 2% at 6 months). Although there was a statistical difference in results between SNS and oBTXA, the clinical relevance is uncertain, particularly with the difference in adverse events.</p><p class="" id=d41170e419>In 2017, Noblett <i>et al</i>. reported the results of a prospective multi-centre study to evaluate sacral neuromodulation over a period of 12 months and found that 80% of patients underwent permanent SNM implantation following a test period<sup><a href="#ref-14">14</a></sup>. Patients with UUI had a mean reduction of 2.2  2.7 leaks per day following implantation (<i>P</i> &lt;0.0001)<sup><a href="#ref-14">14</a></sup>. In 2014, Peeters <i>et al</i>. found that SNM was effective in the long term; the success rate was 70% after a mean follow-up of 46.88 months in patients with UUI<sup><a href="#ref-15">15</a></sup>. A summary of SNS and PTNS is provided in <a href="#T2">Table 2</a>.</p><a name=T2 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 2. Sacral nerve stimulation versus percutaneous nerve stimulation in urge urinary incontinence.</h3></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d41170e458 class=n-a></a><thead><a name=d41170e460 class=n-a></a><tr><a name=d41170e462 class=n-a></a><th align=left colspan=1 rowspan=1><a name=d41170e464 class=n-a></a></th><th align=left colspan=1 rowspan=1 valign=top><a name=d41170e466 class=n-a></a>Sacral nerve<br class=br>stimulation</th><th align=left colspan=1 rowspan=1 valign=top><a name=d41170e471 class=n-a></a>Percutaneous<br class=br>nerve stimulation</th></tr></thead><tbody><a name=d41170e478 class=n-a></a><tr><a name=d41170e480 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e482 class=n-a></a>Improvement in lower<br class=br>urinary tract symptoms</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e487 class=n-a></a>6190%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e490 class=n-a></a>5479%</td></tr><tr><a name=d41170e494 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e496 class=n-a></a>Failure</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e499 class=n-a></a>464%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e502 class=n-a></a>4044%</td></tr><tr><a name=d41170e506 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e508 class=n-a></a>Revision surgery</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e511 class=n-a></a>933%</td><td align=left colspan=1 rowspan=1><a name=d41170e514 class=n-a></a></td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=FN2 class=n-a></a><p id=d41170e523> Data are from Tutolo <i>et al</i>.<sup><a href="#ref-12">12</a></sup> (2018).</p></div></div></div><p class="" id=d41170e536>Currently, NICE guidelines recommend offering SNM to patients if they have not responded to conservative management, including drugs, and they are unable to perform clean intermittent catheterisation (that is, they would be unsuitable for oBTXA) whereas EAU guidelines recommend offering SNM to patients who have UUI refractory to anticholinergic therapy<sup><a href="#ref-6">6</a>,<a href="#ref-7">7</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d41170e549>Percutaneous tibial nerve stimulation</h2><p class="" id=d41170e552>Percutaneous tibial nerve stimulation (PTNS) involves stimulating the sacral nerve plexus for 30 minutes weekly for 12 weeks by placing a needle percutaneously into the posterior tibial nerve peripherally<sup><a href="#ref-16">16</a></sup>. A 2018 systematic review of PTNS found rates of success (cure or improvement) of between 54 and 79%, depending on the definition of success<sup><a href="#ref-12">12</a></sup>. An RCT comparing PTNS with tolterodine found that 79.5% of patients with PTNS had a subjective cure or improvement in symptoms at 12 weeks compared with 54.8% of the tolterodine group, suggesting that PTNS may be a reasonable alternative to anticholinergics<sup><a href="#ref-17">17</a></sup>. MacDiarmid <i>et al</i>. followed up the patients who had responded to PTNS, further treatment being given on demand, and found that the effects of PTNS were sustained between 3 and 12 months<sup><a href="#ref-18">18</a></sup>. Despite encouraging data, long-term data for PTNS are sparse; most studies provide data to 12 weeks only and use varying definitions of success.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d41170e578>Conclusions</h2><p class="" id=d41170e581>Although initial results for PTNS are encouraging, high-level evidence and long-term follow-up data are lacking. It is recommended by NICE as an option only for patients who fail conservative management and do not want or cannot tolerate botulinum toxin or sacral neuromodulation following multi-disciplinary team discussion. SNS treatment for UUI symptoms in OAB is safe and effective in both the short and long term. The ROSETTA trial has shown a statistically significant reduction in UUI with use of oBTXA and SNS. Although the oBTXA group had a significantly increased effect on UUI compared to SNS, the clinical significance remains unclear, particularly as oBTXA has a different side effect profile. At present, both EAU and NICE guidelines recommend that either can be used equally for patients with refractory UUI<sup><a href="#ref-6">6</a>,<a href="#ref-7">7</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d41170e594>Stress urinary incontinence in women</h2><p class="" id=d41170e597>Stress urinary incontinence (SUI) is the involuntary loss of urine on effort or physical exertion, including sneezing or coughing<sup><a href="#ref-1">1</a></sup>. In women, prevalence ranges from 29 to 75%, depending on age, and two broad pathophysiological mechanisms are proposed: urethral hypermobility (weakness in the supporting mechanism of the urethra) and intrinsic sphincter deficiency (defective urethral sphincter mechanism).</p><p class="" id=d41170e604>Initial management of SUI includes weight reduction, pelvic floor muscle training and biofeedback<sup><a href="#ref-4">4</a>,<a href="#ref-5">5</a></sup>. Incontinence pessaries have been used in the past for women who are poor surgical candidates, as has duloxetine, a serotonin and noradrenaline reuptake inhibitor, but neither is recommended by NICE. If conservative management for SUI fails, patients may be offered surgical treatment<sup><a href="#ref-7">7</a></sup>. Surgical options for women include urethral bulking agents and bladder neck suspension procedures, including mid-urethral mesh procedures, pubovaginal slings, colposuspension, and the artificial urinary sphincter (AUS).</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d41170e621>Urethral bulking agents</h2><p class="" id=d41170e624>The injection of bulking agents into the urethral submucosa is a minimally invasive treatment for SUI, improving mucosal coaptation and thus increasing urethral outlet resistance. Several agents are available for use (<a href="#T3">Table 3</a>) whereas others have been withdrawn because of adverse events (Zuidex, Uryz, Polytef and autologous fat). The procedure may be performed in the outpatient day case setting under local anaesthetic. Complications include urethral discomfort, overactive bladder syndrome, temporary urinary incontinence and UTIs<sup><a href="#ref-22">22</a></sup>.</p><a name=T3 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 3. Periurethral bulking agents for stress incontinence.</h3></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d41170e645 class=n-a></a><thead><a name=d41170e647 class=n-a></a><tr><a name=d41170e649 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d41170e651 class=n-a></a>Bulking agent</th><th align=left colspan=1 rowspan=1 valign=top><a name=d41170e654 class=n-a></a>Commercial name</th><th align=left colspan=1 rowspan=1 valign=top><a name=d41170e657 class=n-a></a>Current usage</th></tr></thead><tbody><a name=d41170e662 class=n-a></a><tr><a name=d41170e664 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e666 class=n-a></a>Autologous fat</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e669 class=n-a></a>Autologous fat</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e672 class=n-a></a>Trial terminated (serious adverse event)</td></tr><tr><a name=d41170e676 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e678 class=n-a></a>Carbon coated zirconium beads</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e681 class=n-a></a>Durasphere</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e684 class=n-a></a>Recommended by NICE</td></tr><tr><a name=d41170e688 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e690 class=n-a></a>Polyacrylamide hydrogel</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e693 class=n-a></a>Bulkamid</td><td align=left colspan=1 rowspan=1><a name=d41170e696 class=n-a></a></td></tr><tr><a name=d41170e699 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e701 class=n-a></a>Calcium hydroxlapatite</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e704 class=n-a></a>Coaptite</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e707 class=n-a></a>Approved by FDA</td></tr><tr><a name=d41170e711 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e713 class=n-a></a>Glutaraldehyde X linked with bovine collagen</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e716 class=n-a></a>Contigen</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e719 class=n-a></a>Requires skin test (commonest comparator in<br class=br>trials)</td></tr><tr><a name=d41170e726 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e728 class=n-a></a>Hyaluronic acid with dextranomer</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e731 class=n-a></a>Zuidex</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e734 class=n-a></a>Withdrawn in 2009</td></tr><tr><a name=d41170e738 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e740 class=n-a></a>Porcine dermal implant</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e743 class=n-a></a>Permacol</td><td align=left colspan=1 rowspan=1><a name=d41170e746 class=n-a></a></td></tr><tr><a name=d41170e749 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e751 class=n-a></a>Silicone particles</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e754 class=n-a></a>Macroplastique</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e757 class=n-a></a>Recommended by NICE, approved by FDA</td></tr><tr><a name=d41170e761 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e763 class=n-a></a>Autologous myoblasts</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e766 class=n-a></a>Experimental preparations</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e769 class=n-a></a>Research (not licenced)</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=FN3 class=n-a></a><p id=d41170e779> FDA, US Food and Drug Administration; NICE, National Institute for Health and Care Excellence.</p></div></div></div><p class="" id=d41170e785>High-quality long-term evidence for the use of urethral bulking agents as first-line agents is limited. A Cochrane Review in 2017 found only 14 trials of moderate quality which were not suitable for meta-analysis<sup><a href="#ref-23">23</a></sup>. Bulking agents were compared with placebo, surgical management or collagen in the trials assessed. In the short term, injectables (Macroplastique) provided a better improvement in continence than conservative treatments<sup><a href="#ref-24">24</a></sup>. In two trials which compared surgical treatments with Macroplastique or collagen, surgery resulted in a better objective cure than injectables<sup><a href="#ref-25">25</a>,<a href="#ref-26">26</a></sup>. No clear-cut conclusions could be taken from trials comparing different injectable agents.</p><p class="" id=d41170e803>According to EAU guidelines on urinary incontinence, bulking agents should not be offered to women seeking a permanent cure but may provide short-term improvement in symptoms. Repeat injections may be required<sup><a href="#ref-6">6</a></sup>. NICE supports the short-term use of intra-urethral bulking agents but noted that the benefits diminish with time but may be repeated<sup><a href="#ref-7">7</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d41170e817>Burch colposuspension</h2><p class="" id=d41170e820>The Burch colposuspension was initially described in 1961 and involves suspending the anterior vaginal wall to the ileopectinal ligament (Coopers ligament). This was the gold-standard surgical approach for many years and can be performed by using the open or laparoscopic approach. Complications include bladder perforation, haemorrhage, <i>de novo</i> overactive bladder syndrome and prolapse.</p><p class="" id=d41170e826>An updated Cochrane Database Review in 2017 of 55 trials involving 5517 women found that the overall continence rate for colposuspension was between 85 and 90% at 1 year after procedure and that 70% of patients remained dry at 5 years. Patient-reported incontinence rates were not significantly different between open and laparoscopic colposuspension, but laparoscopic surgery was found to have a lower rate of complications and a shorter length of stay in hospital<sup><a href="#ref-27">27</a></sup>. AUA and EAU guidelines also suggest that open and laparoscopic colposuspension have comparable cure rates.</p><p class="" id=d41170e833>EAU guidelines suggest offering colposuspension (open or laparoscopic) if a mid-urethral sling (MUS) cannot be considered<sup><a href="#ref-6">6</a></sup>. NICE guidelines state that colposuspension, mid-urethral tape or autologous fascial sling can be offered as first-line surgical options but that laparoscopic colposuspension should be offered only by an experienced laparoscopic surgeon working within a multi-disciplinary team<sup><a href="#ref-7">7</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d41170e847>Autologous fascial sling</h2><p class="" id=d41170e850>The autologous fascial pubovaginal sling (PVS) was first popularised by McGuire and Lytton in 1978 and involves harvesting a strip of rectus fascia which is placed suburethrally by using a vaginal incision. In 2007, the Stress Incontinence Surgical Efficacy Trial (SISTEr) reported the results of randomly assigning incontinent women to either PVS or colposuspension. At 24 months, the rate of success (no self-reported SUI, negative stress test and no retreatment) was higher for autologous PVS compared with colposuspension (66% versus 49%), although side effects and need for intervention were more likely<sup><a href="#ref-28">28</a></sup>. At 5 years, patient satisfaction remained high (PVS 83% versus 73%) for both procedures, although continence rates had decreased (PVS 30.8%, colposuspension 24.1%)<sup><a href="#ref-29">29</a></sup>.</p><p class="" id=d41170e861>Schimpf <i>et al</i>. found autologous PVS to be superior to Burch colposuspension when comparing subjective cure rates (odds ratio [OR] 1.65) and to have a lower incidence of UTI, groin pain and bladder/vaginal perforation<sup><a href="#ref-30">30</a></sup>. However, MUS was found to be superior to autologous PVS for subjective cure rates (OR 0.40) and to have a lower incidence of overactive bladder symptoms and retention<sup><a href="#ref-30">30</a></sup>.</p><p class="" id=d41170e875>In 2017, a systematic review of 28 RCTs involving more than 15,000 patients examined comparative data for PVS, colposuspension, tension-free vaginal tape (TVT) and transobturator tape (TOT). Patients undergoing autologous PVS and MUS had similar rates of cure, but MUS had better cure rates than colposuspension. TVT has higher cure rates than TOT though with a higher rate of complications, including bladder perforation, pelvic haematoma, UTIs and voiding symptoms<sup><a href="#ref-31">31</a></sup>. Recently, in a small study of the results of transobturator insertion of autologous fascial sling, Linder and Elliott found that 80% of patients were dry at 4 months; however, long-term data are required to validate this approach<sup><a href="#ref-32">32</a></sup>.</p><p class="" id=d41170e886>In summary, PVS has high satisfaction rates at 5 years compared with colposuspension, although popularity waned with the introduction of the MUS, which does not require the additional morbidity of harvesting of fascia. Increasing patient and surgeon concern with mesh-related complications has renewed interest in PVS because of the lack of mesh-type erosion and pain-related complications.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d41170e892>Mid-urethral synthetic slings</h2><p class="" id=d41170e895>Mid-urethral synthetic sling insertion has become the most common surgical procedure for SUI and largely superseded colposuspension and PVS as a result of the minimally invasive nature and effective cure rate. Ulmsten described the original retropubic tape procedure in 1996: the TVT. This is inserted in a bottom up approach through a suburethral incision in the vagina to the anterior abdominal wall posterior to the pubic symphysis. The SPARC (suprapubic arch) sling system is a top down retropubic sling with complications similar to those of the TVT but is not commonly performed in the UK. Transobturator tapes were developed in the early 2000s, when Delorme introduced an outside in procedure (TOT), and subsequently an inside out procedure (TVT-O) was popularised by de Leval<sup><a href="#ref-33">33</a></sup>. The Cochrane Review of MUS in 2017 reported increased risk of serious intra-operative complications during TVT compared with TOT, including bladder perforation (0.6% versus 4.5%) and more serious but rare complications such as visceral and vascular injury (<a href="#T4">Table 4</a>). Post-operative voiding dysfunction was less frequent after TOT, although the incidence of groin pain was higher (6.4% versus 1.3%) but the incidence of suprapubic pain was lower (0.8% versus 2.9%). The risk of vaginal tape erosion/exposure/extrusion was low in both groups, although the evidence was of low quality<sup><a href="#ref-19">19</a></sup>.</p><a name=T4 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 4. Comparison of transobturator tape and transvaginal tape tapes.</h3></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d41170e920 class=n-a></a><thead><a name=d41170e922 class=n-a></a><tr><a name=d41170e924 class=n-a></a><th align=left colspan=1 rowspan=1><a name=d41170e926 class=n-a></a></th><th align=left colspan=1 rowspan=1 valign=top><a name=d41170e928 class=n-a></a>Transobturator tape</th><th align=left colspan=1 rowspan=1 valign=top><a name=d41170e931 class=n-a></a>Transvaginal tape</th><th align=left colspan=1 rowspan=1 valign=top><a name=d41170e934 class=n-a></a>Risk ratio<br class=br>(confidence interval)</th></tr></thead><tbody><a name=d41170e941 class=n-a></a><tr><a name=d41170e943 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e945 class=n-a></a>Subjective cure 1 year</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e948 class=n-a></a>6298%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e951 class=n-a></a>7197%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e954 class=n-a></a>0.98 (0.961.00)</td></tr><tr><a name=d41170e958 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e960 class=n-a></a>Subjective cure &gt;5 years</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e963 class=n-a></a>4372%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e966 class=n-a></a>5188%</td><td align=left colspan=1 rowspan=1><a name=d41170e969 class=n-a></a></td></tr><tr><a name=d41170e972 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e974 class=n-a></a>Bladder perforation</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e977 class=n-a></a>0.6</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e980 class=n-a></a>4.5</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e983 class=n-a></a>0.13 (0.080.2)</td></tr><tr><a name=d41170e987 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e989 class=n-a></a>Voiding dysfunction</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e992 class=n-a></a>Lower</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e995 class=n-a></a>Increased</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e998 class=n-a></a>0.53 (0.430.65)</td></tr><tr><a name=d41170e1002 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1004 class=n-a></a>Groin pain</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1007 class=n-a></a>6.4</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1010 class=n-a></a>1.3</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1013 class=n-a></a>4.12 (2.716.27)</td></tr><tr><a name=d41170e1018 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1020 class=n-a></a>Suprapubic pain</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1023 class=n-a></a>0.8</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1026 class=n-a></a>2.9</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1029 class=n-a></a>0.29 (0.110.78)</td></tr><tr><a name=d41170e1033 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1035 class=n-a></a>Tape erosion</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1038 class=n-a></a>2.4</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1041 class=n-a></a>2.1</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1044 class=n-a></a>1.13 (0.781.65)</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=FN4 class=n-a></a><p id=d41170e1054> Data are from <a href="#ref-19">19</a>.</p></div></div></div><p class="" id=d41170e1063>Fusco <i>et al</i>. performed an updated systematic review and meta-analysis of the literature to compare the efficacy and safety of MUS with those of Burch colposuspension and pubovaginal slings<sup><a href="#ref-31">31</a></sup>. They found that MUS was significantly superior to Burch colposuspension for overall (OR 0.51) and objective (OR 0.51) cure rates. They had a similar risk of further incontinence surgery and late complications. Retropubic TVT had a higher subjective cure rate (OR 0.83) and objective cure rates (0.82 OR) compared with TVT-O but this was at the cost of higher rates of intra-operative bladder/vaginal perforation, pelvic haematoma and UTI and lower urinary tract symptoms. There were no significant differences in efficacy and safety between inside out and outside in TVT-O<sup><a href="#ref-31">31</a></sup>. There is a risk of intermittent self-catheterisation with both TVT and TVT-O insertion; in a systematic review, Novara <i>et al</i>. reported a 1.5% rate following TVT-O and 3.4% following TVT insertion<sup><a href="#ref-19">19</a></sup>.</p><p class="" id=d41170e1084>Recently, a single-incision mini-sling placed through a single vaginal incision that can be performed under local anaesthetic as a day case was developed<sup><a href="#ref-34">34</a></sup>. However, one type of mini-sling (TVT-Secur,,Ethicon, Somerville, USA) was withdrawn from use because of a higher risk of adverse effects and subsequent data have shown a high failure rate at 3 years compared with retropubic MUS. NICE guidance states that mini-slings should not be used unless special arrangements are in place for clinical governance, consent and research<sup><a href="#ref-7">7</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d41170e1099>Mesh safety</h2><p class="" id=d41170e1102>In recent years, concerns about complications after the use of synthetic mesh for SUI and pelvic organ prolapse (POP) surgery have been voiced by physicians, regulatory bodies, the media and patient websites. These have identified the risk of complications, including mesh erosion, chronic pain, dyspareunia and infections. In some patients, this has resulted in debilitating symptoms requiring major surgery and in large payouts after successful litigation, particularly in the US.</p><p class="" id=d41170e1105>The Scottish Independent Review of the use, safety and efficacy of transvaginal mesh implants in the treatment of SUI and POP in women was reported in March 2017 and concluded that retropubic mesh tape is a valid option to be offered for SUI<sup><a href="#ref-35">35</a></sup>. In addition, Morling <i>et al</i>. carried out a cohort study of 16,660 women in Scotland who had undergone a first single incontinence or prolapse procedure with mesh compared with colposuspension<sup><a href="#ref-36">36</a></sup>. Mesh procedures were found to have a lower risk of immediate complications (adjusted relative risk of 0.44) and subsequent prolapse surgery. Recent advice from several national bodies in the face of unbalanced reports affecting media, legal and patient perception emphasised that patients should be comprehensively counselled about the risks of mesh implantation, together with conservative options and other surgical options available, before proceeding to mesh implantation, which is supported by good evidence when used in appropriate patients by appropriately trained surgeons.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d41170e1122>Artificial urinary sphincter</h2><p class="" id=d41170e1125>The AUS has been used for neurological and recurrent stress incontinence in females for several years but is not in widespread use. Laparoscopic and robotic insertion were first reported in 2015<sup><a href="#ref-37">37</a></sup> and since then the overall numbers of patients and reporting centres have remained comparatively small. In a case series of 52 women with intrinsic sphincteric deficiency and a median follow-up of 24 months, 77% patients were cured and 22% required revision surgery<sup><a href="#ref-38">38</a></sup>. At the end of a study of 26 women with neurogenic incontinence, 58% of patients still had their AUS and 71% of them were continent after a median follow-up of 7.5 years<sup><a href="#ref-39">39</a></sup>.</p><p class="" id=d41170e1140>Two systematic reviews of the performance and safety of AMS 800 AUSs (American Medical Systems, Minnetonka, MN, USA) in female patients were published recently (<a href="#T5">Table 5</a>)<sup><a href="#ref-20">20</a></sup>. The conclusions were based on 12 articles reporting on 886 patients.</p><a name=T5 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 5. Results and complications of artificial urinary sphincter in women.</h3></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d41170e1161 class=n-a></a><thead><a name=d41170e1163 class=n-a></a><tr><a name=d41170e1165 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d41170e1167 class=n-a></a>Intra-operative complications</th><th align=left colspan=1 rowspan=1 valign=top><a name=d41170e1170 class=n-a></a>Results</th></tr></thead><tbody><a name=d41170e1175 class=n-a></a><tr><a name=d41170e1177 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1179 class=n-a></a>Bladder neck injury</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1182 class=n-a></a>043.8%</td></tr><tr><a name=d41170e1186 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1188 class=n-a></a>Vaginal injury</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1191 class=n-a></a>025%</td></tr><tr><a name=d41170e1195 class=n-a></a><td align=left colspan=1 rowspan=1><a name=d41170e1197 class=n-a></a><b>Post-operative results</b></td><td align=left colspan=1 rowspan=1><a name=d41170e1201 class=n-a></a></td></tr><tr><a name=d41170e1204 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1206 class=n-a></a>Continence</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1209 class=n-a></a>61.1100%</td></tr><tr><a name=d41170e1213 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1215 class=n-a></a>Follow-up</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1218 class=n-a></a>5204 months</td></tr><tr><a name=d41170e1223 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1225 class=n-a></a>Erosion</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1228 class=n-a></a>022.2%</td></tr><tr><a name=d41170e1232 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1234 class=n-a></a>Explantation</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1237 class=n-a></a>045.3%</td></tr><tr><a name=d41170e1241 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1243 class=n-a></a>Mechanical failure</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1246 class=n-a></a>044.1%</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=FN5 class=n-a></a><p id=d41170e1256> Data are from <a href="#ref-20">20</a>.</p></div></div></div><p class="" id=d41170e1265>At present, implantation of AUS in female patients is restricted to specialised centres but, despite good success rates, has a high risk of significant morbidity. Well-designed trials with specified indications and long-term follow-up measuring quality-of-life outcomes are required to develop guidelines for AUS implantation in women.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d41170e1271>Conclusions</h2><p class="" id=d41170e1274>Options for treatment for refractory SUI in women include autologous fascial slings, mid-urethral tapes and open colposuspension. Although historically colposuspension was the gold standard, now most patients are offered an autologous sling or mid-urethral tape. EAU guidelines recommend offering MUS to women with uncomplicated SUI as the preferred surgical intervention. NICE guidance recommended MUS, open colposuspension or autologous PVS. Surgeons must discuss the risks and benefits of the different procedures and involve the patient in the choice of treatment, and there is currently a moratorium on MUS in the UK. The approach to recurrent stress incontinence after initial surgery depends on reassessment, and an individualised approach including the same options as primary surgery, with the additional option of AUS.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d41170e1280>Male stress incontinence</h2><p class="" id=d41170e1283>Male SUI most commonly occurs after treatment of prostate cancer following radical prostatectomy and less commonly following transurethral resection of the prostate (TURP). Post-prostatectomy incontinence (PPI) is likely due to a direct injury to the sphincter or damage to adjacent nerves and soft tissue, whereas post-TURP incontinence is more likely to be due to pre-existing abnormal bladder function. The incidence of male post-prostatectomy SUI ranges from 4 to 74%<sup><a href="#ref-40">40</a></sup>. SUI may improve within the first 12 months after surgery, and patients should undergo a trial of pelvic floor muscle training. When conservative management fails, the AUS is considered the gold-standard treatment. Recently, alternatives to the AUS have been developed, such as the male sling and adjustable continence devices in an attempt to make treatment simpler and avoid the mechanical failure risks of the AUS.</p><div class=section><a name=d41170e1290 class=n-a></a><h3 class=section-title>Artificial urinary sphincter</h3><p class="" id=d41170e1295>The AMS 721 was first implanted by Scott, Bradley and Timm in 1972. It consists of three components: a control pump, inflatable cuff and pressure-regulating balloon. The AMS 800 has been the most commonly used device since 1983 and its basic design has largely remained unchanged apart from the introduction of an antibiotic coating, sutureless connectors and smaller cuff sizes<sup><a href="#ref-41">41</a></sup>. The ZSI 375 device (Zephyr Surgical Implants, Geneva, Switzerland) was introduced in 2007 and is a two-part device consisting of a cuff and pump which can be adjusted percutaneously post-operatively<sup><a href="#ref-40">40</a></sup>.</p><p class="" id=d41170e1306>A systematic review by Van der Aa <i>et al</i>. found that social continence rates (&lt;1 pad per day) ranged between 61 and 10% in studies with a mean follow-up of more than 24 months and that 43.5% of patients were dry<sup><a href="#ref-42">42</a></sup>. Infection rates were 8.5% (3.327.8%) and mechanical failure occurred in 6.2% (213.8%). Follow-up of patients at more than 10 years has shown overall continence rates of between 59 and 91%<sup><a href="#ref-42">42</a></sup>. Yafi <i>et al</i>. reported that 79% of patients were dry or had improved continence rates with a 90% increase in quality-of-life scores<sup><a href="#ref-43">43</a></sup>.</p></div><div class=section><a name=d41170e1328 class=n-a></a><h3 class=section-title>Male slings</h3><p class="" id=d41170e1333>Male slings were introduced in 1958 to treat PPI. A wide variety of devices are available; these include bone-anchored, transobturator, adjustable and the newer quadratic sling. Bone-anchored male slings (InVance, American Medical Systems) are anchored to the inferior rami of the pubic bone and provide direct compression of the bulbar urethra with reported continence rates of 13 to 66%. The most commonly reported complication was infection (315%), a potentially serious complication that ultimately led to withdrawal of InVance from the US market<sup><a href="#ref-40">40</a></sup>.</p><p class="" id=d41170e1340>AdVance (American Medical Systems) is a transobturator sling device whose proposed mechanism of action is proximal urethral relocation, although some believe that compression of the bulbar urethra may occur since some patients experience post-operative retention. Rehder <i>et al</i>. reported that 76.8% of 156 patients who used the AdVance device were cured or improved at 3 years<sup><a href="#ref-44">44</a></sup>. Complications include urinary retention (2.715.1%) and perineal pain (417%)<sup><a href="#ref-44">44</a></sup>. In 2010, the modified AdVanceXP was introduced, and Bauer <i>et al</i>. published 36-month follow-up data in a prospective multi-centre study showing a 66% cure rate and 22.5% improvement rate<sup><a href="#ref-45">45</a></sup>. There were no intra-operative or long-term complications and no explantations<sup><a href="#ref-45">45</a></sup>. Critical success factors for the AdVance sling are good mobility of the sphincter area, and compromising factors to success include radiotherapy, bulking agents, prior TURP and urethral fibrosis.</p><p class="" id=d41170e1366>Adjustable slings allow modification of sling tension post-operatively. The Argus (Promedon SA, Crdoba, Argentina) and Remeex (Neomedic International, Barcelona, Spain) devices provide compression to the bulbar urethra with retropubic traction sutures. Hbner <i>et al</i>. showed a success rate of 79% with a median follow-up of 25 months with the Argus device; 39% of patients required adjustment<sup><a href="#ref-46">46</a></sup>. The Remeex device has reported success rates of up to 65% at 32 months<sup><a href="#ref-47">47</a></sup>. Complications include infection (57%), erosion (313%) and explantation in 12 to 35%.</p><p class="" id=d41170e1380>The Adjustable Transobturator Male System (ATOMS) (A.M.I., Feldkirch, Austria) is an adjustable device consisting of a urethral pad with mesh on either side, a titanium port for adjustments and a silicon connection. Friedl <i>et al</i>. conducted a retrospective multi-centre study of 287 men who used the ATOMS device with a median follow-up of 31 months<sup><a href="#ref-48">48</a></sup>. The overall success rate was 90%, and 64% of patients were completely dry. Twenty percent of devices required explantation due to titanium intolerance or leak/dysfunction, and the rate of urinary retention was 3%<sup><a href="#ref-48">48</a></sup>.</p><p class="" id=d41170e1395>Virtue (Coloplast, Minneapolis, MN, USA) is a relatively novel sling device with a hybrid design (two transobturator and two pre-pubic arms). The 12 month follow-up outcomes have shown subjective and objective success rates of 70.9% and 79.2% respectively and no severe adverse events or prolonged retention<sup><a href="#ref-49">49</a></sup>. A summary of a comparison of male slings is provided in <a href="#T6">Table 6</a>.</p><a name=T6 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 6. Results of male sling surgery for stress incontinence.</h3></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d41170e1416 class=n-a></a><thead><a name=d41170e1418 class=n-a></a><tr><a name=d41170e1420 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d41170e1422 class=n-a></a>Sling type</th><th align=left colspan=1 rowspan=1 valign=top><a name=d41170e1425 class=n-a></a>Introduced</th><th align=left colspan=1 rowspan=1 valign=top><a name=d41170e1428 class=n-a></a>Approach</th><th align=left colspan=1 rowspan=1 valign=top><a name=d41170e1431 class=n-a></a>Cure/Dry percentage</th><th align=left colspan=1 rowspan=1 valign=top><a name=d41170e1434 class=n-a></a>Explantation<br class=br>percentage</th></tr></thead><tbody><a name=d41170e1441 class=n-a></a><tr><a name=d41170e1443 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1445 class=n-a></a>Adjustable</td><td align=left colspan=1 rowspan=1><a name=d41170e1448 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d41170e1450 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d41170e1452 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d41170e1454 class=n-a></a></td></tr><tr><a name=d41170e1457 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1459 class=n-a></a>Argus T</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1462 class=n-a></a>2006</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1465 class=n-a></a>Transobturator</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1468 class=n-a></a>60</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1471 class=n-a></a>159</td></tr><tr><a name=d41170e1475 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1477 class=n-a></a>Reemex</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1480 class=n-a></a>2004</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1483 class=n-a></a>Suprapubic</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1486 class=n-a></a>65</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1489 class=n-a></a>12</td></tr><tr><a name=d41170e1493 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1495 class=n-a></a>ATOMS</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1498 class=n-a></a>2009</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1501 class=n-a></a>Transobtorator</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1504 class=n-a></a>60</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1507 class=n-a></a>2030</td></tr><tr><a name=d41170e1511 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1513 class=n-a></a>Non-adjustable</td><td align=left colspan=1 rowspan=1><a name=d41170e1516 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d41170e1518 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d41170e1520 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d41170e1522 class=n-a></a></td></tr><tr><a name=d41170e1526 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1528 class=n-a></a>Advance</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1531 class=n-a></a>2007</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1534 class=n-a></a>Transobturator</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1537 class=n-a></a>3566</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1540 class=n-a></a>1</td></tr><tr><a name=d41170e1544 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1546 class=n-a></a>Virtue</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1549 class=n-a></a>2009</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1552 class=n-a></a>Transobturator</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1555 class=n-a></a>4379</td><td align=left colspan=1 rowspan=1 valign=top><a name=d41170e1558 class=n-a></a>0</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=FN6 class=n-a></a><p id=d41170e1568> Data are from <a href="#ref-21">21</a>. ATOMS, Adjustable Transobturator Male System.</p></div></div></div><p class="" id=d41170e1577>In summary, male slings are a less invasive treatment of PPI compared with AUS, which is attractive to patients as mechanical manipulation of a pump is not required when wanting to void. Most clinicians would use male slings in those with mild to moderate incontinence and adequate residual sphincter function. There is no accepted definition of when to perform a sling or AUS. The results of the Male synthetic sling versus Artificial urinary Sphincter Trial: Evaluation by Randomised control (MASTER) trial, where patients are randomly assigned to either AUS or male sling, will inform on the relative indications for each treatment.</p></div><div class=section><a name=d41170e1581 class=n-a></a><h3 class=section-title>Artificial urinary sphincter versus male slings</h3><p class="" id=d41170e1586>Crivellaro <i>et al</i>. carried out a systematic review of PPI surgical treatments in 2015<sup><a href="#ref-50">50</a></sup>. The authors included articles with more than 12 months of follow-up and defined a successful outcome as the use of zero or one pad per day. They found the AUS to be more efficacious than all sling types (65.7% success AUS, 48.2% InVance and 48.8% AdVance); however, AUS had a higher overall rate of post-operative complications (19.4% versus 7.4% InVance; 12.3% AdVance). However, they also found that the overall quality of studies was poor, and although the AUS had a higher complication rate, this may be due to the longer follow-up<sup><a href="#ref-50">50</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d41170e1604>Conclusions</h2><p class="" id=d41170e1607>AUS is the gold-standard surgical treatment for male SUI, but the use of male sling procedures is becoming more prevalent. Both procedures have been shown to be safe and efficacious; however, there is a lack of good-quality evidence or long-term outcomes or both. Kumar <i>et al</i>. have shown that 75% of patients with moderate SUI prefer a sling over AUS, even against surgeon advice<sup><a href="#ref-51">51</a></sup>. The MASTER trial is a multi-centre RCT that is still recruiting. Patients are randomly assigned to either AUS or male sling with outcomes of patient-reported incontinence at 12 months and cost-effectiveness (measured in quality-adjusted life-years at 24 months). The results of this trial should help guide decision making for both patients and clinicians.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d41170e1 class=n-a></a><h2 class=main-title id=d41386>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d41170e1621 class=n-a></a><h2 class=main-title id=d41170e1623>Abbreviations</h2><p class="" id=d41170e1626>ATOMS, Adjustable Transobturator Male System; AUA, American Association of Urology; AUS, artificial urinary sphincter; EAU, European Association of Urology; MASTER, Male synthetic sling versus Artificial urinary Sphincter Trial: Evaluation by Randomised control; MUS, mid-urethral sling; NICE, National Institute for Health and Care Excellence; OAB, overactive bladder; oBTXA, onabotulinum toxin A; OR, odds ratio; POP, pelvic organ prolapse; PPI, post-prostatectomy incontinence; PTNS, percutaneous nerve stimulation; PVS, pubovaginal sling; RCT, randomised controlled trial; ROSETTA, Refractory Overactive Bladder: Sacral NEuromodulation vs. BoTulinum Toxin Assessment; SNM, sacral neuromodulation; SNS, sacral nerve stimulation; SUI, stress urinary incontinence; TOT, transobturator tape; TURP, transurethral resection of the prostate; TVT, transvaginal tape; TVT-O, transvaginal tension-free vaginal tape-obturator; UTI, urinary tract infection; UUI, urge urinary incontinence</p></div><div class=back-section><a name=d41170e1630 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d41546>References</h2><div class="section ref-list"><a name=d41170e1630 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/5829956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d41170e1637 class=n-a></a>Haylen BT, de Ridder D, Freeman RM, <i> et al.</i>: An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. <i>Neurourol Urodyn.</i> 2010; <b>29</b>(1): 420. <a target=xrefwindow id=d41170e1648 href="http://www.ncbi.nlm.nih.gov/pubmed/19937315">PubMed Abstract </a> | <a target=xrefwindow id=d41170e1651 href="https://doi.org/10.1007/s00192-009-0976-9">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/5829956">F1000 Recommendation</a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718100768"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d41170e1664 class=n-a></a>Milsom I, Coyne KS, Nicholson S, <i> et al.</i>: Global prevalence and economic burden of urgency urinary incontinence: a systematic review. <i>Eur Urol.</i> 2014; <b>65</b>(1): 7995. <a target=xrefwindow id=d41170e1675 href="http://www.ncbi.nlm.nih.gov/pubmed/24007713">PubMed Abstract </a> | <a target=xrefwindow id=d41170e1678 href="https://doi.org/10.1016/j.eururo.2013.08.031">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718100768">F1000 Recommendation</a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d41170e1691 class=n-a></a>Wood LN, Anger JT: Urinary incontinence in women. <i>BMJ.</i> 2014; <b>349</b>: g4531.<a target=xrefwindow id=d41170e1699 href="http://www.ncbi.nlm.nih.gov/pubmed/25225003">PubMed Abstract </a> | <a target=xrefwindow id=d41170e1702 href="https://doi.org/10.1136/bmj.g4531">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d41170e1711 class=n-a></a>Dumoulin C, Hay-Smith EJ: Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. <i>Cochrane Database Syst Rev.</i> 2010; (5): CD005654. <a target=xrefwindow id=d41170e1716 href="http://www.ncbi.nlm.nih.gov/pubmed/24823491">PubMed Abstract </a> | <a target=xrefwindow id=d41170e1719 href="https://doi.org/10.1002/14651858.CD005654.pub3">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d41170e1728 class=n-a></a>Wing RR, West DS, Grady D, <i> et al.</i>: Effect of weight loss on urinary incontinence in overweight and obese women: results at 12 and 18 months. <i>J Urol.</i> 2010; <b>184</b>(3): 100510. <a target=xrefwindow id=d41170e1739 href="http://www.ncbi.nlm.nih.gov/pubmed/20643425">PubMed Abstract </a> | <a target=xrefwindow id=d41170e1742 href="https://doi.org/10.1016/j.juro.2010.05.031">Publisher Full Text </a> | <a target=xrefwindow id=d41170e1746 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3038435">Free Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d41170e1756 class=n-a></a>Burkhard FC, (Chair) Bosch JLHR, Cruz F, <i> et al.</i>: EAU Guidelines on Urinary Incontinence in Adults. 2018. <a target=xrefwindow id=d41170e1761 href="https://uroweb.org/wp-content/uploads/EAU-Guidelines-on-Urinary-Incontinence-2018-large-text.pdf">Reference Source</a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d41170e1770 class=n-a></a>National Institute for Health and Care Excellence: Urinary incontinence in momen:management. NICE Guideline [CG171]. 2015. <a target=xrefwindow id=d41170e1772 href="https://www.nice.org.uk/guidance/cg171">Reference Source</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d41170e1781 class=n-a></a>Chancellor MB, Elovic E, Esquenazi A, <i> et al.</i>: Evidence-based review and assessment of botulinum neurotoxin for the treatment of urologic conditions. <i>Toxicon.</i> 2013; <b>67</b>: 12940. <a target=xrefwindow id=d41170e1792 href="http://www.ncbi.nlm.nih.gov/pubmed/23415704">PubMed Abstract </a> | <a target=xrefwindow id=d41170e1795 href="https://doi.org/10.1016/j.toxicon.2013.01.020">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d41170e1804 class=n-a></a>Nitti VW, Dmochowski R, Herschorn S, <i> et al.</i>: OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial. <i>J Urol.</i> 2017; <b>197</b>(2S): S216S223. <a target=xrefwindow id=d41170e1815 href="http://www.ncbi.nlm.nih.gov/pubmed/28012773">PubMed Abstract </a> | <a target=xrefwindow id=d41170e1818 href="https://doi.org/10.1016/j.juro.2016.10.109">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727772541"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d41170e1827 class=n-a></a>Drake MJ, Nitti VW, Ginsberg DA, <i> et al.</i>: Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta-analysis. <i>BJU Int.</i> 2017; <b>120</b>(5): 611622. <a target=xrefwindow id=d41170e1838 href="http://www.ncbi.nlm.nih.gov/pubmed/28670786">PubMed Abstract </a> | <a target=xrefwindow id=d41170e1841 href="https://doi.org/10.1111/bju.13945">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727772541">F1000 Recommendation</a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d41170e1854 class=n-a></a>Brown ET, Reynolds WS, Kaufman MR, <i> et al.</i>: Advances in the Treatment of Urinary Incontinence in Women. <i>Clin MedInsightsUrol.</i> 2015; <b>8</b>: CMU.S13181. <a target=xrefwindow id=d41170e1865 href="https://doi.org/10.4137/CMU.S13181">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732499717"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d41170e1875 class=n-a></a>Tutolo M, Ammirati E, Heesakkers J, <i> et al.</i>: Efficacy and Safety of Sacral and Percutaneous Tibial Neuromodulation in Non-neurogenic Lower Urinary Tract Dysfunction and Chronic Pelvic Pain: A Systematic Review of the Literature. <i>Eur Urol.</i> 2018; <b>73</b>(3): 406418, pii: S0302-2838(17)30978-8. <a target=xrefwindow id=d41170e1886 href="http://www.ncbi.nlm.nih.gov/pubmed/29336927">PubMed Abstract </a> | <a target=xrefwindow id=d41170e1889 href="https://doi.org/10.1016/j.eururo.2017.11.002">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732499717">F1000 Recommendation</a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726800420"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d41170e1902 class=n-a></a>Amundsen CL, Richter HE, Menefee SA, <i> et al.</i>: OnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women: A Randomized Clinical Trial. <i>JAMA.</i> 2016; <b>316</b>(13): 136674. <a target=xrefwindow id=d41170e1913 href="http://www.ncbi.nlm.nih.gov/pubmed/27701661">PubMed Abstract </a> | <a target=xrefwindow id=d41170e1916 href="https://doi.org/10.1001/jama.2016.14617">Publisher Full Text </a> | <a target=xrefwindow id=d41170e1920 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5399419">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726800420">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725290982"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d41170e1933 class=n-a></a>Noblett K, Siegel S, Mangel J, <i> et al.</i>: Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder. <i>Neurourol Urodyn.</i> 2016; <b>35</b>(2): 24651. <a target=xrefwindow id=d41170e1944 href="http://www.ncbi.nlm.nih.gov/pubmed/25546568">PubMed Abstract </a> | <a target=xrefwindow id=d41170e1947 href="https://doi.org/10.1002/nau.22707">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725290982">F1000 Recommendation</a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d41170e1960 class=n-a></a>Peeters K, Sahai A, De Ridder D, <i> et al.</i>: Long-term follow-up of sacral neuromodulation for lower urinary tract dysfunction. <i>BJU Int.</i> 2014; <b>113</b>(5): 78994. <a target=xrefwindow id=d41170e1971 href="http://www.ncbi.nlm.nih.gov/pubmed/24238278">PubMed Abstract </a> | <a target=xrefwindow id=d41170e1974 href="https://doi.org/10.1111/bju.12571">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d41170e1983 class=n-a></a>Peters KM, Carrico DJ, Wooldridge LS, <i> et al.</i>: Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study. <i>J Urol.</i> 2013; <b>189</b>(6): 2194201. <a target=xrefwindow id=d41170e1994 href="http://www.ncbi.nlm.nih.gov/pubmed/23219541">PubMed Abstract </a> | <a target=xrefwindow id=d41170e1997 href="https://doi.org/10.1016/j.juro.2012.11.175">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1346960"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d41170e2006 class=n-a></a>Peters KM, MacDiarmid SA, Wooldridge LS, <i> et al.</i>: Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. <i>J Urol.</i> 2009; <b>182</b>(3): 105561. <a target=xrefwindow id=d41170e2017 href="http://www.ncbi.nlm.nih.gov/pubmed/19616802">PubMed Abstract </a> | <a target=xrefwindow id=d41170e2020 href="https://doi.org/10.1016/j.juro.2009.05.045">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1346960">F1000 Recommendation</a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d41170e2034 class=n-a></a>MacDiarmid SA, Peters KM, Shobeiri SA, <i> et al.</i>: Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder. <i>J Urol.</i> 2010; <b>183</b>(1): 23440. <a target=xrefwindow id=d41170e2045 href="http://www.ncbi.nlm.nih.gov/pubmed/19913821">PubMed Abstract </a> | <a target=xrefwindow id=d41170e2048 href="https://doi.org/10.1016/j.juro.2009.08.160">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d41170e2057 class=n-a></a>Novara G, Artibani W, Barber MD, <i> et al.</i>: Updated systematic review and meta-analysis of the comparative data on colposuspensions, pubovaginal slings, and midurethral tapes in the surgical treatment of female stress urinary incontinence. <i>Eur Urol.</i> 2010; <b>58</b>(2): 21838. <a target=xrefwindow id=d41170e2068 href="http://www.ncbi.nlm.nih.gov/pubmed/20434257">PubMed Abstract </a> | <a target=xrefwindow id=d41170e2071 href="https://doi.org/10.1016/j.eururo.2010.04.022">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734199629"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d41170e2080 class=n-a></a>Peyronnet B, O'Connor E, Khavari R, <i> et al.</i>: AMS-800 Artificial urinary sphincter in female patients with stress urinary incontinence: A systematic review. <i>Neurourol Urodyn.</i> 2018. <a target=xrefwindow id=d41170e2088 href="http://www.ncbi.nlm.nih.gov/pubmed/30298943">PubMed Abstract </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734199629">F1000 Recommendation</a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/736209279"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d41170e2101 class=n-a></a>Chung E: Contemporary surgical devices for male stress urinary incontinence: a review of technological advances in current continence surgery. <i>Transl Androl Urol.</i> 2017; <b>6</b>(Suppl 2): S112S121. <a target=xrefwindow id=d41170e2109 href="http://www.ncbi.nlm.nih.gov/pubmed/28791230">PubMed Abstract </a> | <a target=xrefwindow id=d41170e2112 href="https://doi.org/10.21037/tau.2017.04.12">Publisher Full Text </a> | <a target=xrefwindow id=d41170e2115 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5522789">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/736209279">F1000 Recommendation</a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d41170e2128 class=n-a></a>Leone Roberti Maggiore U, Bogani G, Meschia M, <i> et al.</i>: Urethral bulking agents versus other surgical procedures for the treatment of female stress urinary incontinence: a systematic review and meta-analysis. <i>Eur J Obstet Gynecol Reprod Biol.</i> 2015; <b>189</b>: 4854. <a target=xrefwindow id=d41170e2139 href="http://www.ncbi.nlm.nih.gov/pubmed/25855326">PubMed Abstract </a> | <a target=xrefwindow id=d41170e2142 href="https://doi.org/10.1016/j.ejogrb.2015.03.025">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727835358"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d41170e2151 class=n-a></a>Kirchin V, Page T, Keegan PE, <i> et al.</i>: Urethral injection therapy for urinary incontinence in women. <i>Cochrane Database Syst Rev.</i> 2017; <b>7</b>(Suppl 1): CD003881. <a target=xrefwindow id=d41170e2162 href="http://www.ncbi.nlm.nih.gov/pubmed/28738443">PubMed Abstract </a> | <a target=xrefwindow id=d41170e2165 href="https://doi.org/10.1002/14651858.CD003881.pub4">Publisher Full Text </a> | <a target=xrefwindow id=d41170e2169 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6483304">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727835358">F1000 Recommendation</a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d41170e2183 class=n-a></a>ter Meulen PH, Berghmans LC, Nieman FH, <i> et al.</i>: Effects of Macroplastique Implantation System for stress urinary incontinence and urethral hypermobility in women. <i>Int Urogynecol J Pelvic Floor Dysfunct.</i> 2009; <b>20</b>(2): 17783. <a target=xrefwindow id=d41170e2194 href="http://www.ncbi.nlm.nih.gov/pubmed/18936867">PubMed Abstract </a> | <a target=xrefwindow id=d41170e2197 href="https://doi.org/10.1007/s00192-008-0741-5">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d41170e2206 class=n-a></a>Corcos J, Collet JP, Shapiro S, <i> et al.</i>: Multicenter randomized clinical trial comparing surgery and collagen injections for treatment of female stress urinary incontinence. <i>Urology.</i> 2005; <b>65</b>(5): 898904. <a target=xrefwindow id=d41170e2217 href="http://www.ncbi.nlm.nih.gov/pubmed/15882720">PubMed Abstract </a> | <a target=xrefwindow id=d41170e2220 href="https://doi.org/10.1016/j.urology.2004.11.054">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d41170e2229 class=n-a></a>Maher CF, O'Reilly BA, Dwyer PL, <i> et al.</i>: Pubovaginal sling versus transurethral Macroplastique for stress urinary incontinence and intrinsic sphincter deficiency: A prospective randomised controlled trial. <i>BJOG.</i> 2005; <b>112</b>(6): 797801. <a target=xrefwindow id=d41170e2240 href="http://www.ncbi.nlm.nih.gov/pubmed/15924540">PubMed Abstract </a> | <a target=xrefwindow id=d41170e2243 href="https://doi.org/10.1111/j.1471-0528.2005.00547.x">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727838723"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d41170e2252 class=n-a></a>Lapitan MCM, Cody JD, Mashayekhi A: Open retropubic colposuspension for urinary incontinence in women. <i>Cochrane Database Syst Rev.</i> 2017; <b>177</b>: CD002912. <a target=xrefwindow id=d41170e2260 href="http://www.ncbi.nlm.nih.gov/pubmed/28741303">PubMed Abstract </a> | <a target=xrefwindow id=d41170e2263 href="https://doi.org/10.1002/14651858.CD002912.pub7">Publisher Full Text </a> | <a target=xrefwindow id=d41170e2266 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6483458">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727838723">F1000 Recommendation</a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1091158"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d41170e2279 class=n-a></a>Albo ME, Richter HE, Brubaker L, <i> et al.</i>: Burch colposuspension versus fascial sling to reduce urinary stress incontinence. <i>N Engl J Med.</i> 2007; <b>356</b>(21): 214355. <a target=xrefwindow id=d41170e2290 href="http://www.ncbi.nlm.nih.gov/pubmed/17517855">PubMed Abstract </a> | <a target=xrefwindow id=d41170e2293 href="https://doi.org/10.1056/NEJMoa070416">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1091158">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/716497829"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d41170e2306 class=n-a></a>Brubaker L, Richter HE, Norton PA, <i> et al.</i>: 5-Year Continence Rates, Satisfaction and Adverse Events of Burch Urethropexy and Fascial Sling Surgery for Urinary Incontinence. <i>J Urol.</i> 2012; <b>187</b>(4): 132430. <a target=xrefwindow id=d41170e2317 href="http://www.ncbi.nlm.nih.gov/pubmed/22341290">PubMed Abstract </a> | <a target=xrefwindow id=d41170e2320 href="https://doi.org/10.1016/j.juro.2011.11.087">Publisher Full Text </a> | <a target=xrefwindow id=d41170e2324 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3586411">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/716497829">F1000 Recommendation</a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d41170e2338 class=n-a></a>Schimpf MO, Rahn DD, Wheeler TL, <i> et al.</i>: Sling surgery for stress urinary incontinence in women: A systematic review and metaanalysis. <i>Am J Obstet Gynecol.</i> 2014; <b>211</b>(1): 71.e171.e27. <a target=xrefwindow id=d41170e2349 href="http://www.ncbi.nlm.nih.gov/pubmed/24487005">PubMed Abstract </a> | <a target=xrefwindow id=d41170e2352 href="https://doi.org/10.1016/j.ajog.2014.01.030">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727593784"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d41170e2361 class=n-a></a>Fusco F, Abdel-Fattah M, Chapple CR, <i> et al.</i>: Updated Systematic Review and Meta-analysis of the Comparative Data on Colposuspensions, Pubovaginal Slings, and Midurethral Tapes in the Surgical Treatment of Female Stress Urinary Incontinence. <i>Eur Urol.</i> 2017; <b>72</b>(4): 56791. <a target=xrefwindow id=d41170e2372 href="http://www.ncbi.nlm.nih.gov/pubmed/28479203">PubMed Abstract </a> | <a target=xrefwindow id=d41170e2375 href="https://doi.org/10.1016/j.eururo.2017.04.026">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727593784">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d41170e2388 class=n-a></a>Linder BJ, Elliott DS: Autologous transobturator urethral sling placement for female stress urinary incontinence. <i>J Urol.</i> 2015; <b>193</b>(3): 9916. <a target=xrefwindow id=d41170e2396 href="http://www.ncbi.nlm.nih.gov/pubmed/25444955">PubMed Abstract </a> | <a target=xrefwindow id=d41170e2399 href="https://doi.org/10.1016/j.juro.2014.08.125">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d41170e2408 class=n-a></a>Imran R, Kearney R: Surgical management of stress urinary incontinence. <i>Obstet Gynaecol Reprod Med.</i> 2016; <b>26</b>(1): 205. <a target=xrefwindow id=d41170e2416 href="https://doi.org/10.1016/j.ogrm.2015.11.002">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d41170e2425 class=n-a></a>Basu M, Duckett J: Three-year results from a randomised trial of a retropubic mid-urethral sling versus the Miniarc single incision sling for stress urinary incontinence. <i>Int Urogynecol J.</i> 2013; <b>24</b>(12): 205964. <a target=xrefwindow id=d41170e2433 href="http://www.ncbi.nlm.nih.gov/pubmed/23712578">PubMed Abstract </a> | <a target=xrefwindow id=d41170e2436 href="https://doi.org/10.1007/s00192-013-2125-8">Publisher Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d41170e2445 class=n-a></a>Scottish Independent Review of the use, safety and efficacy of transvaginal mesh implants in the treatment of stress urinary incontinence and pelvic organ prolapse in women. accessed 6/5/18. <a target=xrefwindow id=d41170e2447 href="http://www.gov.scot/Resource/0051/00515856.pdf">Reference Source</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727142931"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d41170e2457 class=n-a></a>Morling JR, McAllister DA, Agur W, <i> et al.</i>: Adverse events after first, single, mesh and non-mesh surgical procedures for stress urinary incontinence and pelvic organ prolapse in Scotland, 1997-2016: a population-based cohort study. <i>Lancet.</i> 2017; <b>389</b>(10069): 62940. <a target=xrefwindow id=d41170e2468 href="http://www.ncbi.nlm.nih.gov/pubmed/28010993">PubMed Abstract </a> | <a target=xrefwindow id=d41170e2471 href="https://doi.org/10.1016/S0140-6736(16)32572-7">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727142931">F1000 Recommendation</a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d41170e2484 class=n-a></a>Biardeau X, Rizk J, Marcelli F, <i> et al.</i>: Robot-assisted laparoscopic approach for artificial urinary sphincter implantation in 11 women with urinary stress incontinence: surgical technique and initial experience. <i>Eur Urol.</i> 2015; <b>67</b>(5): 93742. <a target=xrefwindow id=d41170e2495 href="http://www.ncbi.nlm.nih.gov/pubmed/25582931">PubMed Abstract </a> | <a target=xrefwindow id=d41170e2498 href="https://doi.org/10.1016/j.eururo.2014.12.041">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727321082"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d41170e2507 class=n-a></a>Ferreira C, Brychaert PE, Menard J, <i> et al.</i>: Laparoscopic implantation of artificial urinary sphincter in women with intrinsic sphincter deficiency: Mid-term outcomes. <i>Int J Urol.</i> 2017; <b>24</b>(4): 30813. <a target=xrefwindow id=d41170e2518 href="http://www.ncbi.nlm.nih.gov/pubmed/28215049">PubMed Abstract </a> | <a target=xrefwindow id=d41170e2521 href="https://doi.org/10.1111/iju.13296">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727321082">F1000 Recommendation</a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726288870"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d41170e2534 class=n-a></a>Ph V, Lon P, Granger B, <i> et al.</i>: Stress urinary incontinence in female neurological patients: Long-term functional outcomes after artificial urinary sphincter (AMS 800<sup>TM</sup>) implantation. <i>Neurourol Urodyn.</i> 2017; <b>36</b>(3): 7649. <a target=xrefwindow id=d41170e2548 href="http://www.ncbi.nlm.nih.gov/pubmed/27080729">PubMed Abstract </a> | <a target=xrefwindow id=d41170e2552 href="https://doi.org/10.1002/nau.23019">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726288870">F1000 Recommendation</a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d41170e2565 class=n-a></a>Ostrowski I, led E, Ciechan J, <i> et al.</i>: Current interventional management of male stress urinary incontinence following urological procedures. <i>Cent European J Urol.</i> 2015; <b>68</b>(3): 3407. <a target=xrefwindow id=d41170e2576 href="http://www.ncbi.nlm.nih.gov/pubmed/26568879">PubMed Abstract </a> | <a target=xrefwindow id=d41170e2579 href="https://doi.org/10.5173/ceju.2015.616">Publisher Full Text </a> | <a target=xrefwindow id=d41170e2583 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4643709">Free Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d41170e2592 class=n-a></a>James MH, McCammon KA: Artificial urinary sphincter for post-prostatectomy incontinence: A review. <i>Int J Urol.</i> 2014; <b>21</b>(6): 53643. <a target=xrefwindow id=d41170e2600 href="http://www.ncbi.nlm.nih.gov/pubmed/24528387">PubMed Abstract </a> | <a target=xrefwindow id=d41170e2603 href="https://doi.org/10.1111/iju.12392">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717969553"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d41170e2613 class=n-a></a>van der Aa F, Drake MJ, Kasyan GR, <i> et al.</i>: The artificial urinary sphincter after a quarter of a century: A critical systematic review of its use in male non-neurogenic incontinence. <i>Eur Urol.</i> 2013; <b>63</b>(4): 6819. <a target=xrefwindow id=d41170e2624 href="http://www.ncbi.nlm.nih.gov/pubmed/23219375">PubMed Abstract </a> | <a target=xrefwindow id=d41170e2627 href="https://doi.org/10.1016/j.eururo.2012.11.034">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717969553">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727478963"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d41170e2640 class=n-a></a>Yafi FA, Powers MK, Zurawin JP, <i> et al.</i>: Contemporary Review of Artificial Urinary Sphincters for Male Stress Urinary Incontinence. <i>Sex Med Rev.</i> 2016; <b>4</b>(2): 15766. <a target=xrefwindow id=d41170e2651 href="http://www.ncbi.nlm.nih.gov/pubmed/27872025">PubMed Abstract </a> | <a target=xrefwindow id=d41170e2654 href="https://doi.org/10.1016/j.sxmr.2015.11.004">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727478963">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d41170e2667 class=n-a></a>Rehder P, Haab F, Cornu JN, <i> et al.</i>: Treatment of postprostatectomy male urinary incontinence with the transobturator retroluminal repositioning sling suspension: 3-year follow-up. <i>Eur Urol.</i> 2012; <b>62</b>(1): 1405. <a target=xrefwindow id=d41170e2678 href="http://www.ncbi.nlm.nih.gov/pubmed/22386196">PubMed Abstract </a> | <a target=xrefwindow id=d41170e2681 href="https://doi.org/10.1016/j.eururo.2012.02.038">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726994805"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d41170e2690 class=n-a></a>Bauer RM, Grabbert MT, Klehr B, <i> et al.</i>: 36-month data for the AdVance XP male sling: results of a prospective multicentre study. <i>BJU Int.</i> 2017; <b>119</b>(4): 62630. <a target=xrefwindow id=d41170e2701 href="http://www.ncbi.nlm.nih.gov/pubmed/27862836">PubMed Abstract </a> | <a target=xrefwindow id=d41170e2704 href="https://doi.org/10.1111/bju.13704">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726994805">F1000 Recommendation</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d41170e2717 class=n-a></a>Hbner WA, Gallistl H, Rutkowski M, <i> et al.</i>: Adjustable bulbourethral male sling: experience after 101 cases of moderate-to-severe male stress urinary incontinence. <i>BJU Int.</i> 2011; <b>107</b>(5): 77782. <a target=xrefwindow id=d41170e2728 href="http://www.ncbi.nlm.nih.gov/pubmed/20964801">PubMed Abstract </a> | <a target=xrefwindow id=d41170e2731 href="https://doi.org/10.1111/j.1464-410X.2010.09619.x">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d41170e2740 class=n-a></a>Trost L, Elliott DS: Male stress urinary incontinence: a review of surgical treatment options and outcomes. <i>Adv Urol.</i> 2012; <b>2012</b>: 287489. <a target=xrefwindow id=d41170e2748 href="http://www.ncbi.nlm.nih.gov/pubmed/22649446">PubMed Abstract </a> | <a target=xrefwindow id=d41170e2751 href="https://doi.org/10.1155/2012/287489">Publisher Full Text </a> | <a target=xrefwindow id=d41170e2754 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3356867">Free Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727004604"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d41170e2764 class=n-a></a>Friedl A, Mhlstdt S, Zachoval R, <i> et al.</i>: Long-term outcome of the adjustable transobturator male system (ATOMS): results of a European multicentre study. <i>BJU Int.</i> 2017; <b>119</b>(5): 78592. <a target=xrefwindow id=d41170e2775 href="http://www.ncbi.nlm.nih.gov/pubmed/27868328">PubMed Abstract </a> | <a target=xrefwindow id=d41170e2778 href="https://doi.org/10.1111/bju.13684">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727004604">F1000 Recommendation</a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d41170e2791 class=n-a></a>Comiter CV, Rhee EY, Tu LM, <i> et al.</i>: The virtue sling--a new quadratic sling for postprostatectomy incontinence--results of a multinational clinical trial. <i>Urology.</i> 2014; <b>84</b>(2): 4338. <a target=xrefwindow id=d41170e2802 href="http://www.ncbi.nlm.nih.gov/pubmed/24972946">PubMed Abstract </a> | <a target=xrefwindow id=d41170e2805 href="https://doi.org/10.1016/j.urology.2014.02.062">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725804306"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d41170e2814 class=n-a></a>Crivellaro S, Morlacco A, Bodo G, <i> et al.</i>: Systematic review of surgical treatment of post radical prostatectomy stress urinary incontinence. <i>Neurourol Urodyn.</i> 2016; <b>35</b>(8): 87581. <a target=xrefwindow id=d41170e2825 href="http://www.ncbi.nlm.nih.gov/pubmed/26397171">PubMed Abstract </a> | <a target=xrefwindow id=d41170e2828 href="https://doi.org/10.1002/nau.22873">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725804306">F1000 Recommendation</a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d41170e2841 class=n-a></a>Kumar A, Litt ER, Ballert KN, <i> et al.</i>: Artificial urinary sphincter versus male sling for post-prostatectomy incontinence--what do patients choose? <i>J Urol.</i> 2009; <b>181</b>(3): 12315. <a target=xrefwindow id=d41170e2852 href="http://www.ncbi.nlm.nih.gov/pubmed/19152937">PubMed Abstract </a> | <a target=xrefwindow id=d41170e2855 href="https://doi.org/10.1016/j.juro.2008.11.022">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 31 Jul 2019</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/8-1294/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/8-1294/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Department of Urology, Royal Hallamshire Hospital, Glossop Road, Sheffield, S10 2JF, UK<br/> <p> <div class=margin-bottom> Alison Downey <br/> <span>Roles: </span> Writing  Original Draft Preparation, Writing  Review & Editing </div> <div class=margin-bottom> Richard D. Inman <br/> <span>Roles: </span> Formal Analysis, Methodology, Project Administration, Supervision, Validation, Writing  Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/8-1294/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 31 Jul 2019, 8:1294 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.16356.1">https://doi.org/10.12688/f1000research.16356.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden">  2019 Downey A and Inman RD. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=17866 data-id=16356 data-downloads="" data-views="" data-scholar="10.12688/f1000research.16356.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/8-1294/v1/pdf?article_uuid=fad0225b-4af5-4659-b977-d8e8f4cc5dfa" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.16356.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Downey A and Inman RD. Recent advances in surgical management of urinary incontinence [version 1; peer review: 2 approved] <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):1294 (<a href="https://doi.org/10.12688/f1000research.16356.1" target=_blank>https://doi.org/10.12688/f1000research.16356.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=16356 id=mobile-track-article-signin-16356 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/16356?target=/articles/8-1294/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=17866 /> <input name=articleId type=hidden value=16356 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Wayne J. G. Hellstrom</strong>, Department of Urology, Tulane University Health Sciences Center, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> <span class=approved-referee__co-referee> <strong>Pete Tsambarlis</strong>, Department of Urology, Tulane University Health Sciences Center , USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>David Waltregny</strong>, Academic Department of Urology, University Hospital of Liege, Belgium </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 31 Jul 2019</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/8-1294/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/8-1294/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=14436-51416></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=54354-51419></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/8-1294/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>31 Jul 19</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Wayne J. G. Hellstrom</strong>, Department of Urology, Tulane University Health Sciences Center, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> <p class=" u-mt--2 u-mb--1/2"><strong>Pete Tsambarlis</strong>, Department of Urology, Tulane University Health Sciences Center , USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>David Waltregny</strong>, Academic Department of Urology, University Hospital of Liege, Belgium </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/8-1294/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/8-1294/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in surgical management of...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/8-1294/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/8-1294/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/8-1294/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Downey A and Inman RD');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/8-1294/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/8-1294",
            templates : {
                twitter : "Recent advances in surgical management of urinary incontinence. Downey A and Inman RD, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/8-1294/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in surgical management of urinary incontinence", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in surgical management of urinary incontinence", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/16356/17866")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "17866");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "51416": 0,
                           "51419": 1,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "1d8f7c8d-e3d1-4637-aee2-4dbbd17b3e5f";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-1294.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-1294.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-1294.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/8-1294.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/8-1294.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>